Improving Outcomes in Oral Cancer

A Clinical and Translational Update
1. Auflage 2020
ISBN: 978-3-030-30093-7
Verlag: Springer International Publishing

Buch, Englisch, 189 Seiten, Format (B × H): 183 mm x 260 mm, Gewicht: 629 g

This book brings together experts in the field of maxillofacial and head and neck oncology to provide a comprehensive clinical and translational update on oral cancer that focuses especially on prognosis. Readers will find up-to-date information on disease staging and the pathological, genetic, and surgical factors that affect patient outcomes. Individual chapters describe the most recent advances in radiotherapy, chemotherapy, and immunotherapy, again with careful analysis of the treatment-related factors relevant to response and survival. Management of premalignant lesions and risk factors for malignant transformation are discussed, and the latest knowledge on chemoprevention is presented. Further topics to be addressed include reconstruction of oral cancer defects, salvage options in the event of recurrence, and the prediction of quality of life following treatment. The book will be of value to all clinicians who care for patients with oral cancer in their everyday practice.

Zielgruppe

Professional/practitioner

Autoren/Hrsg.

Kademani, Deepak

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Zahnmedizin
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Chirurgie Mund-, Kiefer- & Gesichtschirurgie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Onkologie, Krebsforschung

Inhaltsverzeichnis

Oral Epithelial Dysplasia.- Chemoprevention in Oral Cancer.- Diagnostic Adjuncts for Screening and Surveillance in Head and Neck Cancer.- Current Updates in Staging and Prognosis in Oral Cancer.- Surgical Factors Affecting Outcomes in Oral Cancer.- Pathological Factors Affecting Outcomes in Oral Cancer.- Genetic Factors Affecting Outcomes in Oral Cancer.- Factors Affecting Response and Survival in Radiotherapy.- Novel and Emerging Chemotherapeutic Agents in Head and Neck Cancer.- Immunotherapy in Oral Cancer.- Recurrent Oral Cancer and Salvage Options.- Reconstruction of Oral Cancer Defects.- Predicting QOL After Oral Cancer Treatment.

Über Autor(innen)

Deepak Kademani, DMD, MD, FACS, is Chief of Staff, Medical Director, Oral and Maxillofacial Surgery; and Fellowship Director, Oral/Head and Neck Oncologic and Reconstructive Surgery at North Memorial Medical Center, Minneapolis, MN, USA. In addition to his clinical and teaching responsibilities, Dr. Kademani conducts research especially on oral cancer and salivary gland disorders, benign and malignant disease of the head and neck, and head and neck reconstruction. He has been a Diplomate of the American Board of Oral and Maxillofacial Surgery since 2005 and a Fellow of the American College of Surgeons since 2006. He is a member of the editorial board for the Journal of Oral Cancer and has acted as a reviewer for numerous journals. Dr. Kademani has been the lead or co-author on more than 40 papers in peer-reviewed medical journals and is co-editor (with G.P. Tiwana) of the book Atlas of Oral and Maxillofacial Surgery (Elsevier 2015).